Bentham Science Logo

Current Vascular Pharmacology

Volume 17, 6 Issues, 2019
ISSN: 1875-6212 (Online)
ISSN: 1570-1611 (Print)
This journal supports open access

Most Cited Articles

Review Article

Is nonalcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome?

, 1 May 2018; 16(3): 219-227.

Niki Katsiki, Pablo Perez-Martinez, Panagiotis Anagnostis, Dimitri P. Mikhailidis* and Asterios Karagiannis

DOI: 10.2174/1570161115666170621075619

Review Article

Renal denervation therapy: Can it contribute to better blood pressure control in hypertension?

, 1 January 2018; 16(1): 66-69.

Costas Tsioufis*, Kyriakos Dimitriadis, Athanasios Kordalis, Michalis Doumas, Dimitris Konstantinidis, Theodoros Kalos, Felix Mahfoud, Vasilios Papademetriou and Dimitrios Tousoulis

DOI: 10.2174/1570161115666170426151649

Research Article

Effect of low (5 mg) vs. high (20-40 mg) rosuvastatin dose on 24h arterial stiffness, central haemodynamics, and non-alcoholic fatty liver disease in patients with optimally controlled arterial hypertension

, 2018; 16(4): 393-400.

Eudoxia Mitsiou*, Chrysoula Boutari, Vasilios Kotsis, Eleni Georgianou, Michael Doumas, Asterios Karagiannis and Vasilios G. Athyros*

DOI: 10.2174/1570161115666170630122833

Research Article

Ultrasound-assisted catheter-directed thrombolysis in high-risk and intermediate-high-risk pulmonary embolism: A meta-analysis

, 2018; 16(2): 179-189.

Cihangir Kaymaz*, Ozgur Yasar Akbal, Ibrahim Halil Tanboga, Aykun Hakgor, Fatih Yilmaz, Selcuk Ozturk, Nertila Poci, Sevim Turkday, Nihal Ozdemir and Stavros Konstantinides

DOI: 10.2174/1570161115666170404122535

Review Article

Lifestyle modifications in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

, 1 May 2018; 16(3): 239-245.

Konstantinos Stavropoulos, Konstantinos Imprialos, Andreas Pittaras, Charles Faselis, Puneet Narayan and Peter Kokkinos*

DOI: 10.2174/1570161115666170621080835

Research Article

Vitamin d levels in middle-aged patients with obstructive sleep apnoea syndrome

, 1 May 2018; 16(3): 289-297.

K. Archontogeorgis, E. Nena, N. Papanas, A. Zissimopoulos, A. Voulgaris, M. Xanthoudaki, V. Manolopoulos, M. Froudarakis and P. Steiropoulos*

DOI: 10.2174/1570161115666170529085708

Review Article

Nonalcoholic fatty liver disease vs. nonalcoholic steatohepatitis: Pathological and clinical implications

, 1 May 2018; 16(3): 214-218.

Chrysoula Boutari*, Petros Lefkos, Vasilios G. Athyros, Asterios Karagiannis and Konstantinos Tziomalos

DOI: 10.2174/1570161115666170621075157

Review Article

Antidiabetic drugs as antihypertensives: New data on the horizon

, 1 January 2018; 16(1): 70-78.

Vassiliki Mamakou, Ioanna Eleftheriadou, Niki Katsiki, Konstantinos Makrilakis, Konstantinos Tsioufis and Nikolaos Tentolouris*

DOI: 10.2174/1570161115666171010122332

Review Article

Statins: An under-appreciated asset for the prevention and the treatment of NAFLD or NASH and the related cardiovascular risk

, 1 May 2018; 16(3): 246-253.

Vasilios G. Athyros*, Chrysa Boutari, Konstantinos Stavropoulos, Panagiotis Anagnostis, Konstantinos P. Imprialos, Michael Doumas and Asterios Karagiannis

DOI: 10.2174/1570161115666170621082910


Diabetes and atherosclerosis: Old players in a new field, osteoporosis

, 2018; 16(6): 524-527.

Stavroula A. Paschou*, Panagiotis Anagnostis, Andromachi Vryonidou and Dimitrios G. Goulis

DOI: 10.2174/1570161116666171205104851

Review Article

Sexual dysfunction, cardiovascular risk and effects of pharmacotherapy

, 1 March 2018; 16(2): 130-142.

Konstantinos P. Imprialos*, Konstantinos Stavropoulos, Michael Doumas, Konstantinos Tziomalos, Asterios Karagiannis and Vasilios G. Athyros

DOI: 10.2174/1570161115666170609101502

Review Article

The Co-existence of NASH and chronic kidney disease boosts cardiovascular risk: Are there any common therapeutic options?

, 1 May 2018; 16(3): 254-268.

Marianna Papademetriou, Vasilios G. Athyros, Eleni Geladari, Michael Doumas, Costas Tsioufis and Vasilios Papademetriou*

DOI: 10.2174/1570161115666170621081638

Review Article

Can serum uric acid lowering therapy contribute to the prevention or treatment of nonalcoholic fatty liver disease?

, 1 May 2018; 16(3): 269-275.

Paschalis Paschos, Vasilios G. Athyros, Achilleas Tsimperidis, Anastasia Katsoula, Nikolaos Grammatikos and Olga Giouleme*

DOI: 10.2174/1570161115666170621082237

Review Article

Klotho-FGF23, cardiovascular disease, and vascular calcification: Black or white?

, 2018; 16(2): 143-156.

Giuseppe Cianciolo, Andrea Galassi, Irene Capelli, Roberto Schillaci, Gaetano La Manna and Mario Cozzolino*

DOI: 10.2174/1570161115666170310092202

Related Journals

Related eBooks

eBooks Catalog